Targeted knockdown of the B lineage transcriptional activator E2A in B cell chronic lymphocytic leukemia (CLL) enhances lenalidomide sensitivity and regulates cellular proliferation (88.7)
Year: 2009
Type: conference-abstract
Source: The Journal of Immunology
Institutions: University of Pittsburgh, UPMC Hillman Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7904379